Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 933.14M | 965.26M | 1.22B | 1.34B | 1.21B | 897.02M |
Gross Profit | 345.00K | 9.72M | 15.65M | -27.55M | 67.78M | 52.86M |
EBITDA | -31.01M | -26.76M | 2.60M | -12.75M | 61.89M | 51.15M |
Net Income | -66.83M | -58.98M | -28.00M | -41.60M | 46.08M | -17.28M |
Balance Sheet | ||||||
Total Assets | 393.06M | 401.44M | 454.24M | 478.32M | 484.95M | 476.82M |
Cash, Cash Equivalents and Short-Term Investments | 30.49M | 35.47M | 30.01M | 36.46M | 50.61M | 47.67M |
Total Debt | 138.72M | 114.67M | 105.46M | 87.27M | 63.65M | 108.23M |
Total Liabilities | 185.22M | 176.38M | 174.68M | 170.23M | 139.74M | 180.58M |
Stockholders Equity | 207.84M | 225.06M | 279.56M | 308.09M | 345.21M | 296.24M |
Cash Flow | ||||||
Free Cash Flow | -13.09M | -14.59M | -7.51M | -31.70M | 10.44M | 65.20M |
Operating Cash Flow | -10.30M | -3.52M | 22.02M | 6.05M | 26.82M | 71.78M |
Investing Cash Flow | -11.90M | -13.47M | -33.03M | -37.66M | 27.12M | 23.32M |
Financing Cash Flow | 24.28M | 7.72M | 6.96M | 19.01M | -40.00M | -66.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $1.02B | 20.87 | 9.47% | ― | -9.57% | -24.85% | |
61 Neutral | $10.37B | 6.45 | -0.08% | 2.84% | 3.09% | -36.03% | |
61 Neutral | $569.19M | 40.51 | 2.92% | 1.07% | -6.20% | -80.00% | |
59 Neutral | $697.62M | ― | -18.95% | ― | -15.66% | -237.12% | |
56 Neutral | $403.87M | ― | -11.71% | ― | 341.75% | 20.16% | |
48 Neutral | $90.56M | ― | -28.22% | ― | -12.70% | -74.32% | |
43 Neutral | $88.08M | ― | 103.25% | 1.63% | -7.97% | 13.42% |
On June 23, 2025, Alto Ingredients, Inc. received a notification from Nasdaq confirming that the company’s stock price had met the minimum requirement of $1.00 per share for 10 consecutive business days, thus regaining compliance with Nasdaq’s listing rules. This development ensures the company’s continued listing on the Nasdaq Stock Market, which is crucial for maintaining investor confidence and market presence.
On June 25, 2025, Alto Ingredients, Inc. held its Annual Meeting of Stockholders, where several key proposals were approved. The meeting resulted in the election of six directors, approval of executive compensation, a recommendation for the frequency of advisory votes on executive compensation, and the ratification of RSM US LLP as the independent accounting firm for 2025.